Dosimetric comparison of IMRT and IMPT in the treatment of recurrent nasopharyngeal carcinoma

被引：0
|
作者：
Hung, H. M. [1 ]
Chan, O. C. M. [2 ]
Mak, C. H. [1 ]
Ng, W. T. [1 ]
Lee, M. C. H. [2 ]
Hung, W. M. [1 ]
机构：
[1] Pamela Youde Nethersole Eastern Hosp, Clin Oncol, Chai Wan, Hong Kong, Peoples R China
[2] Pamela Youde Nethersole Eastern Hosp, Med Phys, Chai Wan, Hong Kong, Peoples R China
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PH-0169
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [1] Dosimetric comparison between IMRT and Hyperarc in re-RT of recurrent nasopharyngeal carcinoma
    Tong, K. K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S654 - S655
  • [2] The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT
    Ng, Wai Tong
    Lee, Michael C. H.
    Chang, Amy T. Y.
    Chan, Oscar S. H.
    Chan, Lucy L. K.
    Cheung, Foon Yiu
    Hung, Wai Man
    Chan, Connie C. C.
    Lee, Anne W. M.
    [J]. ORAL ONCOLOGY, 2014, 50 (05) : 506 - 512
  • [3] A Dosimetric Comparison of IMPT, DSPT, and IMRT for Low Risk Prostate Cancer
    Corradetti, M. N.
    Vapiwala, N.
    Zhai, H.
    Lin, H.
    Bui, V.
    Deville, C.
    Bekelman, J.
    Christodouleas, J.
    Tochner, Z.
    Both, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S444 - S445
  • [4] Dosimetric benefit on adaptive IMPT for patients with locally advanced nasopharyngeal carcinoma
    Lam, W. W.
    Lee, H. F. V.
    Cheung, K. Y.
    Yu, S. K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S638 - S638
  • [5] Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma
    Hung, Hing Ming
    Chan, Oliver Cheuk Ming
    Mak, Chi Hang
    Hung, Wai Man
    Ng, Wai Tong
    Lee, Michael Chi Hang
    [J]. MEDICAL DOSIMETRY, 2022, 47 (01) : 14 - 19
  • [6] Dosimetric predictors of persistent xerostomia after IMRT for nasopharyngeal carcinoma
    Fourati, N.
    Zouari, S.
    Frikha, M.
    Fessi, Z.
    Siala, W.
    Mnejja, W.
    Daoud, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S958 - S959
  • [7] Dosimetric predictors of hypothyroidism in nasopharyngeal carcinoma patients treated with IMRT
    Zhou, L.
    Chen, J.
    Shen, W.
    Chen, M.
    Chen, Y.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S445 - S445
  • [8] Recurrent nasopharyngeal cancer: Dosimetric considerations for Retreatment with CyberKnife versus IMRT
    Yom, S. S.
    Chuang, C. F.
    Huang, K.
    Quivey, J. M.
    Phillips, T. L.
    Xia, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S386 - S386
  • [9] Recurrent nasopharyngeal carcinoma: hyperfractionation of IMRT improves outcomes
    Killock, David
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (05) : 283 - 283
  • [10] Recurrent nasopharyngeal carcinoma: hyperfractionation of IMRT improves outcomes
    David Killock
    [J]. Nature Reviews Clinical Oncology, 2023, 20 : 283 - 283
12345